Request for Covid-19 Impact Assessment of this Report
Insulin is a peptide hormone secreted by beta cells of the pancreatic islets and is considered to be the main anabolic hormone of the human body. It allows the cells of the body to use glucose for energy. When there is excess glucose in the bloodstream, insulin increases the storage of glucose as glycogen and fat. Insulin is administered externally to patients suffering from diabetes, which is the medical condition when the body is unable to maintain its blood glucose level.
Market Dynamics
The rapid growth of the insulin market is fuelled by increasing prevalence of diabetes, the rise in geriatric population, an increase in obesity, propagation of diabetes management awareness and government impetus. The generally unhealthy lifestyle of the present generation has added another dimension to the complex issue.
However, parallel factors like high cost of insulin, rising cost of insurance coverage, high competition and stringent regulations are restraining the growth of the market.
New and innovative insulin products, their commoditization and increased demand in untapped emerging economies are opportunities for the several key players in the market.
Market Segmentation
The market is segmented on various parameters. The first segment for insulin drugs is based on the mode of action into rapid-acting, intermediate-acting, long-acting and premixed insulin derivatives. This categorization is based on how fast insulin starts to work and for how long its effect lasts.
Another market segment is based on the type of insulin used - human insulin and analogue insulin. Human insulin describes synthetic insulin which is laboratory grown to mimic the insulin in humans. Analogue insulin is a genetically altered form of human insulin. Since it has a more uniform action, it is slowly replacing human insulin as the preferred form of insulin.
The market for insulin delivery devices is segmented into insulin syringes, insulin pens, insulin pumps, and insulin jet injections. Each has its own USP - Insulin syringes are user-friendly and self-administrable, pens are compact in size and reusable, pumps are easily wearable by patients and jet injections are needleless. However, the market leader in terms of revenue is insulin pumps.
Regional/Geographic Analysis
In terms of geography, the global insulin market is segmented into North America, Europe, Asia-Pacific and LAMEA (Latin America, Middle East & Africa). The market is dominated by North America due to the high prevalence of diabetes and technological advances in efficient insulin delivery while Asia-Pacific has the fastest growing market for human insulin.
Key Players
Some of the major players in the market include Novo Nordisk, Sanofi-Aventis, Merck & Co, Pfizer, Eli Lilly and Biocon constituting the top 6 in the Global Insulin market.
The report contains comprehensive analysis on:
--> Global Insulin Market Segments
--> Global Insulin Market Drivers, Restraints and Opportunities
--> Global Insulin Market Size & Forecast 2016 to 2022
--> Supply & Demand Value Chain
--> Global Insulin Market Current Trends
--> Competition & Major Companies
--> Technology and R&D Status
--> Porters Five Force Analysis
--> Strategic and Critical Success Factor Analysis of Key Players
Regional analysis for Global Insulin Market includes
--> North America
>> US and Canada
--> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
--> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
--> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
--> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
--> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macro-economic factors and other qualitative and quantitative insights. The impact of all such factors are delivered across multiple market segments and geographies.
Report Highlights::
--> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
--> Consumer and Pricing Analysis
--> Market dynamics of the industry
--> In-depth Market Segmentation
--> Historical and Projected Market Sizing in terms of volume and value
--> Recent market trends and Impact Factors
--> R&D Status and Technology Overview
--> Extensive Industry Structure Coverage
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...